incomplete abortion
Conditions
Interventions
water for injection as placebo
Sponsors
Federal Government of Nigeria through the Medical residency training fund
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria 1. Patients diagnosed with 1st trimester incomplete miscarriage 2. Patients with no prior adverse reaction to hyoscine butylbromide and lignocaine 3. Women meeting the above criteria who will give consent to participate in the study. 4. Women within the reproductive age group (15-49 years)
Exclusion criteria
Exclusion criteria: 1. Patients who do not give consent 2. Women with history of previous adverse drug reaction to hyoscine butyl-bromide or lignocaine 3. Women with any contraindication to hyoscine butyl-bromide. 4. Women taking medications with drug interaction to hyoscine butyl-bromide (antihistamines, ipratropium, metoclopramide and tricyclic antidepressants) or lignocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in intraprocedural pain scores for the experimental group | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse side effect to hyoscine butylbromide and patients post procedural satisfaction will be the secondary outcome | — |
Countries
Nigeria
Contacts
Public ContactMaryam Ali
Public enquiries
Outcome results
None listed